- PR Newswire•4 days ago
RALEIGH, N.C., Sept. 21, 2016 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer, will present at the Ladenburg ...
- Zacks•5 days ago
BioDelivery Sciences International, Inc. (BDSI) has secured improved positioning for Bunavail (buprenorphine and naloxone) under three new managed care contracts.
BioDelivery Sciences International, Inc. (BDSI)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||2.71 x 1500|
|Ask||2.78 x 10000|
|Day's Range||2.55 - 2.81|
|52wk Range||1.86 - 7.04|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-3.14|
|Avg Vol (3m)||713,642|
|Dividend & Yield||N/A (N/A)|